News
Entries for the first-ever Awards must be made by the end of the day ahead of the closing date
In World Alzheimer’s Month, expert Peter Schüler reflects on the potential implications of new Alzheimer’s therapies on the research landscape.
World Alzheimer’s Month offers an opportunity to reflect on the progress made in the search of effective treatments for this enormously burdensome disease and align our visions for the future. This year, there is much progress to consider as we expect two further medicines, donanemab and lecanemab, to come to market. These drugs offer more treatment alternatives to aducanumab as disease-modifying (DM) treatments in addition to the long-existing symptomatic therapies. In addition to slowing the progression of the disease by 25-35% per year, the successful developments of these drugs provided some additionally encouraging results – namely that the countless disappointments in the past 20 years have led to valuable lessons learned which, in turn, helped to refine the methodologies for Alzheimer’s Disease (AD) drug development.
US scientists are delving deeper into the role of a specific form of cholesterol known as very-low-density lipoprotein (VLDL) in various conditions including stroke. The journey to uncover the influence of cholesterol in cardiovascular health traces back to the pioneering work of François Poulletier de la Salle, who, in 1769, successfully isolated cholesterol from a [...]
A coalition of health charities and professional bodies last week came together at the Scottish Parliament to demand that access to rehabilitation is recognised as a human right in law. Tens of thousands of people across Scotland are currently not receiving the rehabilitation they require, with the recent Stroke Improvement Programme stated that an estimated [...]
Entrants now have until September 8 to make their submissions to the inaugural Awards
How person-centred care and understanding can make a life-changing difference
Entrepreneur Ian Pearce shares the lessons he learned on the journey to establishing his innovation, Neuro ProActive, within the NHS.
My journey for the last six years has been interesting. After my father had a stroke, I experienced a lot of the frustrations that hundreds of thousands of people do each year. It seemed to me that while many of these challenges needed basic solutions, those challenges were numerous and long standing. In late 2017, while having a shower, I started to think about a single digital platform which would be all encompassing for NHS and private practice clinicians, as well as patients and family members. Most of my best ideas happen in the bathroom. It’s the only place where men can multi-task and escape young children. For any potential supplier to want to “crack” the NHS, I’d make two points. Firstly, this is the wrong mindset. The NHS doesn’t want to be “cracked”. Secondly, it’s a huge mistake to see the NHS as one organisation. It’s also important to appreciate that the views in this article are my own, based on my experiences over a five-year period.
How they feel about their sleep quality is more important than data from a sleep tracker, study reveals
Inaugural NR Times Awards highlights work of the professionals involved in patients' progress
A new tool has been developed to help determine the level of unmet need in community neuro-rehab around the country, which has already helped to lay bare the alarming lack of provision in the area of England it was created.
The audit tool gains insight from professionals across the multi-disciplinary team and highlights what a patient needs in all aspects of their rehab, in comparison to what they they actually receive, collecting the vital localised data to make a case to commissioners.
